-transparent.png){kind=logo}
A series of ten novel chalcone incorporated quinazoline derivatives (11a-11j) were designed and synthesized. All the synthesized compounds were evaluated for their anticancer activities against four human cancer cell lines (A549, HT-29, MCF-7 and A375). Among them, four compounds, 11f, 11g, 11i and 11j showed more potent anticancer activity than the control drug, Combretastatin - A4.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
September 2019,
Molecules (Basel, Switzerland),
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
November 2010,
ChemMedChem,
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
January 2015,
Anti-cancer agents in medicinal chemistry,
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
October 2020,
Molecules (Basel, Switzerland),
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
November 2022,
BMC chemistry,
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
September 2011,
European journal of medicinal chemistry,
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
March 2012,
Expert opinion on therapeutic patents,
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
June 2012,
Bioorganic & medicinal chemistry letters,
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
May 2017,
MedChemComm,
Sapavat Madhavi, and
Reddymasu Sreenivasulu, and
Jyothsna Pragathi Yazala, and
Rudraraju Ramesh Raju
November 2017,
Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society,
